Pharma Links 2013-05-22

http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads_6.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_9.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_8.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_7.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads_4.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Direct-to-consumer-Advertising.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_4.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_3.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_2.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_10.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Emerging-Markets-Growing-By-Double-Digits-In-Annual-Health-Spending.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Pharma-Ad-Spending-On-Emerging-Markets-Digital.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Pharma-Apps-For-Ipad-And-Mobiles.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads_5.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Best-Biotechs-And-Pharmas-To-Work-For.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads_3.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads_2.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets_6.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets_5.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets_4.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets_3.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets_2.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_6.htm
http://pharma.about.com/od/BigPharma/p/Baxter-International-Inc.htm
http://pharma.about.com/od/BigPharma/p/Glaxosmithkline-Gsk.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Study-Younger-Physicians-More-Skeptical-Of-Vaccines.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Survey-Its-Common-For-U-s-Medical-Students-To-Receive-Industry-Gifts.htm
http://pharma.about.com/od/BigPharma/p/Teva-Pharmaceutical-Industries-Ltd.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_5.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-Changing-Face-Of-The-Anti-Depressant-Drug-Market.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-China-Pharmaceutical-Market.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-Smoking-Cessation-Drug-Market.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Data-Mining-Doctors-Prescribing-History.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Pharmaceutical-Companies-Test-Opportunities-In-Russia.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-Most-Prescribed-Medications-By-Drug-Class.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2012.htm
http://pharma.about.com/od/FDA/a/Firms-Make-Fda-Adverse-Event-Report-Data-Accessible.htm
http://pharma.about.com/od/FDA/a/Encouraging-Rare-Diseases-Products-Development.htm
http://pharma.about.com/od/FDA/a/Diabetes-Drug-Approval-Process.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-Rise-Of-Lifestyle-Drugs.htm
http://pharma.about.com/od/FDA/a/All-About-Viibryd.htm
http://pharma.about.com/od/FDA/a/Adverseevents-Inc.htm
http://pharma.about.com/od/FDA/a/2012-Renewal-Of-The-Prescription-Drug-User-Fee-Act-Pdufa.htm
http://pharma.about.com/od/Profiles/Pharmaceutical-Company-Profiles.htm
http://pharma.about.com/b/2011/06/14/survey-most-americans-have-their-children-vaccinated-but-express-safety-concerns.htm
http://pharma.about.com/od/DrugBasics/Drug-Basics.htm
http://pharma.about.com/od/Manufacturing-and-Technology/Manufacturing-And-Technology.htm
http://pharma.about.com/od/FDA/Fda-Approval.htm
http://pharma.about.com/od/Government_IP/Government-And-Intellectual-Property.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Going-Green-Is-Good-For-Business.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Anti-Obesity-Drug-Market-Trends.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Pharmaceutical-Companies-Flock-To-Brazil.htm
http://pharma.about.com/od/Sales_and_Marketing/a/What-Strategies-Can-A-Pharma-Marketer-Use-To-Reach-Doctors.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Anti-Obesity-Drug-Market-Trends_2.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Physician-Attitudes-Toward-Industry-Marketing.htm
http://pharma.about.com/od/FDA/a/Viibryd-First-New-Antidepressant-In-A-Decade.htm
http://pharma.about.com/od/Sales_and_Marketing/Sales-And-Marketing.htm
http://pharma.about.com/od/BigPharma/Big-Pharma.htm
http://pharma.about.com/od/Manufacturing-and-Technology/i/Drug-Shortages_2.htm
http://pharma.about.com/od/Manufacturing-and-Technology/i/Drug-Shortages.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Pharmas-And-Fda-Inspections.htm
http://pharma.about.com/od/BigPharma/p/Johnson-And-Johnson-Jandj.htm
http://pharma.about.com/od/Insurance-and-Medicare/Insurance-And-Medicare-Medicaid.htm
http://pharma.about.com/od/Clinical-Trials/Clinical_Trials.htm
http://pharma.about.com/od/
http://pharma.about.com/od/D/Definitions-Of-Pharmaceutical-Terms.htm
http://pharma.about.com/od/B/B.htm
http://pharma.about.com/od/O/O.htm
http://pharma.about.com/od/M/M.htm
http://pharma.about.com/od/N/N.htm
http://pharma.about.com/od/Research-and-Development/Research-And-Development.htm
http://pharma.about.com/od/P/P.htm
http://pharma.about.com/od/Generics/Generics-And-Biosimilars.htm
http://pharma.about.com/od/A/A.htm
http://pharma.about.com/b/2013/05/15/global-vaccine-use-surveillance-tool-tracks-public-perceptions.htm
http://pharma.about.com/b/2013/05/13/fda-approves-breo-ellipta-for-copd.htm
http://pharma.about.com/b/2012/08/04/fda-approves-sanofis-colon-cancer-drug.htm
http://pharma.about.com/b/2012/05/28/revlimid-associated-with-secondary-cancers.htm
http://pharma.about.com/b/2011/08/17/industry-grows-restless-waiting-for-fdas-social-media-guidance.htm
http://pharma.about.com/b/2012/11/30/johnson-johnson-wont-enforce-hiv-drug-patent-in-africa.htm
http://pharma.about.com/b/2013/05/07/pfizer-tackles-multiple-problems-by-selling-viagra-online.htm
http://pharma.about.com/od/DrugBasics/a/What-Were-Some-Of-The-Most-Important-Drug-Discoveries.htm
http://pharma.about.com/od/DrugBasics/a/Drugs-101-What-Is-A-Drug.htm
http://pharma.about.com/od/Clinical-Trials/a/Check-In-On-The-Male-Contraceptive-Research.htm
http://pharma.about.com/od/Clinical-Trials/a/Europe-Tiptoes-Towards-Publication-Of-Raw-Clinical-Trial-Data.htm
http://pharma.about.com/od/Clinical-Trials/a/The-Vaccine-Development-Process.htm
http://pharma.about.com/od/Clinical-Trials/a/Nida-Backs-Research-Of-Potential-Meth-Addiction-Drug.htm
http://pharma.about.com/od/Clinical-Trials/a/Opportunities-And-Challenges-Of-Pediatric-Clinical-Drug-Trials.htm
http://pharma.about.com/od/Clinical-Trials/a/Rating-Clinical-Trials.htm
http://pharma.about.com/od/Clinical-Trials/a/Clinical-Trials-Phases.htm
http://pharma.about.com/od/Clinical-Trials/a/Clinical-Trials-Training-Opportunities.htm
http://pharma.about.com/od/Research-and-Development/a/European-Researchers-Re-purpose-Drugs-For-Ms.htm
http://pharma.about.com/od/Research-and-Development/a/Un-Says-New-Drugs-Are-Winning-The-War-On-Aids.htm
http://pharma.about.com/od/Research-and-Development/a/Which-Pharmas-Spend-The-Most-On-Randd.htm
http://pharma.about.com/od/Research-and-Development/a/Hiv-Aids-Drug-Market.htm
http://pharma.about.com/od/Research-and-Development/a/What-Are-The-Elements-Of-A-Research-Article.htm
http://pharma.about.com/od/Research-and-Development/a/Tuberculosis-Drug-Discovery-Advances.htm
http://pharma.about.com/od/Research-and-Development/a/Alternatives-To-Warfarin-For-Stroke-Prevention.htm
http://pharma.about.com/od/Research-and-Development/a/Addressing-The-Antibiotics-Crisis.htm
http://pharma.about.com/od/Research-and-Development/a/The-Addiction-Medications-Tool-Chest.htm
http://pharma.about.com/od/Research-and-Development/a/Pharmas-Still-Finding-New-Uses-For-Botulinum-Toxin.htm
http://pharma.about.com/od/Research-and-Development/a/Who-Funds-Biomedical-Research.htm
http://pharma.about.com/od/Research-and-Development/a/diabetespipeline.htm
http://pharma.about.com/od/Research-and-Development/a/Arms-New-Drugs-Could-Tease-Out-Antibodies-To-Fight-Infections-Cancer.htm
http://pharma.about.com/od/Insurance-and-Medicare/a/Medicare-Waste-And-Monitoring.htm
http://pharma.about.com/od/Insurance-and-Medicare/a/Specialty-Pharmacies.htm
http://pharma.about.com/od/Insurance-and-Medicare/a/Government-Health-Plans-And-The-Pharmaceutical-Industry.htm
http://pharma.about.com/od/Insurance-and-Medicare/i/Negotiating-Part-D_2.htm
http://pharma.about.com/od/Insurance-and-Medicare/i/Negotiating-Part-D.htm
http://pharma.about.com/od/Generics/a/Generic-Drug-Pipeline.htm
http://pharma.about.com/od/Generics/a/Top-Generic-Drug-Companies.htm
http://pharma.about.com/od/Generics/a/Generic-Drug-Launches.htm
http://pharma.about.com/od/Government_IP/a/Drug-Classifications.htm
http://pharma.about.com/od/Government_IP/a/Pharmas-And-The-Stop-Internet-Piracy-Act.htm
http://pharma.about.com/od/Government_IP/a/Ip-Laws-And-Pharma.htm
http://pharma.about.com/od/Government_IP/a/How-Are-Annual-Fees-On-Prescription-Drug-Manufacturers-Assessed.htm
http://pharma.about.com/od/Government_IP/a/Should-Pediatricians-Fire-Families-For-Refusing-Vaccines.htm
http://pharma.about.com/od/Government_IP/a/How-Are-Pharma-Companies-Preparing-For-Proposed-Changes-To-U-S-Health-Care.htm
http://pharma.about.com/od/Government_IP/a/Global-Treaty-On-Mercury-Reduction-Fans-Thimerosal-In-Vaccines-Debate.htm
http://pharma.about.com/od/Government_IP/a/The-Patent-Reform-Act-Of-2011-And-The-Pharmaceutical-Industry.htm
http://pharma.about.com/od/Government_IP/a/U-S-Supreme-Court-Upholds-Bulk-Of-Affordable-Care-Act.htm
http://pharma.about.com/od/Government_IP/a/Are-Pay-For-Delay-Settlements-History.htm
http://pharma.about.com/od/Government_IP/i/Gene-Patents.htm
http://pharma.about.com/od/Government_IP/i/Preventing-Counterfeit-Drug-Trade.htm
http://pharma.about.com/od/Government_IP/i/Gene-Patents_2.htm
http://pharma.about.com/od/Government_IP/i/Preventing-Counterfeit-Drug-Trade_2.htm
http://pharma.about.com/od/BigPharma/a/Which-Popular-Drugs-Are-Going-Off-Patent-In-2013-2016.htm
http://pharma.about.com/od/BigPharma/a/Wikileaks-Cables-Show-Diplomats-Aggressively-Promote-Pharmaceutical-Industry.htm
http://pharma.about.com/b/2011/06/08/dr-reddys-soon-to-be-a-household-name.htm
http://pharma.about.com/od/Over-the-Counter-Medicine/Over-The-Counter-Medicine.htm
http://pharma.about.com/od/Philanthropy/Philanthropy.htm
http://pharma.about.com/b/2013/05/06/fda-make-tevas-plan-b-available-for-all.htm
http://pharma.about.com/b/2013/04/30/explore-the-history-of-medicine-site.htm
http://pharma.about.com/b/archives.htm
http://pharma.about.com/b/2013/04/30/tax-breaks-for-baxter-healthcare-riles-some-minn-legislators.htm
http://pharma.about.com/b/2013/04/28/actavis-settles-with-purdue-pharma-will-market-generic-oxycontin-pending-fda-approval.htm
http://pharma.about.com/b/2013/04/22/fda-failed-to-act-on-faulty-drug-research.htm
http://pharma.about.com/b/2013/02/28/groups-combat-industry-influence-on-medical-school-campuses.htm
http://pharma.about.com/b/2013/04/13/generic-drug-prices-start-to-fall-in-canadian-provinces.htm
http://pharma.about.com/b/2013/04/01/novartis-says-indian-patent-ruling-will-discourage-future-investment.htm
http://pharma.about.com/od/Glossary/Pharma-A-to-Z.htm
http://pharma.about.com/od/C/C.htm
http://pharma.about.com/b/2011/04/11/obesity-drug-back-in-play-following-positive-trial-results.htm
http://pharma.about.com/b/2013/01/10/pharmas-report-flu-drug-shortages.htm
http://pharma.about.com/b/2012/07/11/fda-opioid-makers-must-provide-safe-use-training-to-prescribers.htm
http://pharma.about.com/b/2012/02/22/pharma-employment-still-taking-hits.htm
http://pharma.about.com/b/2013/03/31/ketamine-explored-as-suicide-prevention-drug.htm
http://pharma.about.com/b/2013/03/31/study-varenicline-improves-smokers-chances-of-quitting.htm
http://pharma.about.com/b/2013/03/31/consumer-reports-finds-wide-gaps-in-pharmacy-generic-pricing.htm
http://pharma.about.com/od/C/g/Current-Good-Manufacturing-Practices-Cgmps.htm
http://pharma.about.com/od/B/g/Biogeneric-Drugs.htm
http://pharma.about.com/od/Research-and-Development/u/Innovations.htm
http://pharma.about.com/b/2013/03/31/uk-union-of-physicians-signs-on-to-alltrials-campaign.htm
http://pharma.about.com/b/2013/03/24/gop-legislators-propose-an-fda-oversight-board.htm
http://pharma.about.com/b/2013/02/28/when-flaws-escape-the-peer-reviewers.htm
http://pharma.about.com/b/2013/03/22/supreme-court-to-hear-pay-for-delay-arguments.htm
http://pharma.about.com/b/2013/03/19/founder-of-generic-powerhouse-dr-reddys-passed-away.htm
http://pharma.about.com/b/2011/05/25/74-percent-and-growing-most-prescriptions-now-written-for-generic-drugs.htm
http://pharma.about.com/b/2011/06/13/wisc-otc-manufacturer-distributor-face-fda-injunction.htm
http://pharma.about.com/b/2013/03/10/ncats-making-old-and-abandoned-drugs-a-starting-point-for-new-therapies.htm
http://pharma.about.com/b/
http://pharma.about.com/od/Sales_and_Marketing/tp/Top-Multiple-Sclerosis-Drugs.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/Top-Branded-Drug-Sales-For-2011.htm
http://pharma.about.com/od/Sales_and_Marketing/u/Markets.htm
http://pharma.about.com/od/P/g/Peer-Review.htm
http://pharma.about.com/od/B/g/A-Definition.htm
http://pharma.about.com/od/D/g/Definition-Of-Double-blind-Trial.htm
http://pharma.about.com/b/2013/02/26/fda-approves-third-drug-to-treat-gastrointestinal-tumors.htm
http://pharma.about.com/b/2013/02/25/dtc-campaign-planned-for-new-arthritis-drug.htm
http://pharma.about.com/od/B/g/Biologic-License-Application-Bla.htm
http://pharma.about.com/b/2013/02/21/vaccine-infographic-tells-the-story.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/PharmaNewsSites.01.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/PharmaNewsSites.htm
http://pharma.about.com/b/2013/02/19/phrma-will-fight-rebates-for-low-income-drug-beneficiaries.htm
http://pharma.about.com/b/2013/02/02/amgen-fires-back-on-criticism-of-special-congressional-treatment.htm
http://pharma.about.com/b/2013/01/21/cdc-multi-resitant-tb-drugs-in-short-supply-for-years.htm
http://pharma.about.com/b/2013/01/01/pharmas-doing-business-in-australia-to-disclose-physician-payments.htm
http://pharma.about.com/b/2013/01/28/takeda-pharmaceuticals-gets-a-triple-play-with-new-type-2-diabetes-drug-approvals.htm
http://pharma.about.com/b/2013/01/30/institut-curie-to-license-genome-mapping-technology-to-industry-partner.htm
http://pharma.about.com/b/2013/01/30/two-groups-to-host-specialty-pharmacy-conference.htm
http://pharma.about.com/b/2013/01/31/mercks-oxytrol-patch-for-overactive-bladder-approved-for-otc.htm
http://pharma.about.com/b/2013/01/31/pfizer-continues-to-scale-back-rd-investment.htm
http://pharma.about.com/b/2013/01/31/scientists-resume-work-on-h5n1-avian-flu-virus.htm
http://pharma.about.com/b/2013/02/05/uk-physicians-and-med-students-object-to-bad-guidelines.htm
http://pharma.about.com/b/2010/12/14/patient-privacy-concerns-precede-smart-pills.htm
http://pharma.about.com/b/2010/12/10/noose-tightens-on-rogue-online-pharmacies.htm
http://pharma.about.com/b/2010/12/17/pharmas-eye-brazil.htm
http://pharma.about.com/b/2010/12/06/wikileaked-cable-lists-pharmas-vital-to-national-security.htm
http://pharma.about.com/b/2010/12/05/bare-truth-in-love-and-other-drugs.htm
http://pharma.about.com/b/2010/11/19/pharmas-make-top-green-rankings.htm
http://pharma.about.com/b/2010/10/14/website-promotes-patient-adherance.htm
http://pharma.about.com/b/2010/10/14/combat-mad-scientist-myth.htm
http://pharma.about.com/b/2010/10/14/another-anti-obesity-hopeful-about-to-bite-the-dust.htm
http://pharma.about.com/b/2011/01/09/fda-requires-addition-to-clinical-trial-informed-consent-documents.htm
http://pharma.about.com/b/2010/12/29/genetic-study-shows-how-50-year-old-drug-helps-people-with-diabetes.htm
http://pharma.about.com/b/2010/12/20/pharmas-tops-in-settlements-paid-to-government.htm
http://pharma.about.com/b/2011/01/14/india-adds-barcode-requirement-on-pharma-exports.htm
http://pharma.about.com/b/2011/03/25/oops-fda-new-drug-approvals-tally-excludes-biologics.htm
http://pharma.about.com/b/2011/03/27/human-gene-patents-in-limbo.htm
http://pharma.about.com/b/2011/03/07/collaborative-pharmas-and-union-workers-break-adversary-strereotypes.htm
http://pharma.about.com/b/2011/02/28/fujifilm-and-samsung-stake-claim-on-biologics-future.htm
http://pharma.about.com/b/2011/02/11/senators-propose-early-warning-of-drug-shortages.htm
http://pharma.about.com/b/2011/01/26/phrma-gives-sotu-speech-a-thumbs-up.htm
http://pharma.about.com/b/2011/01/23/pharma-ad-spending-down-in-2010.htm
http://pharma.about.com/b/2011/04/30/embryonic-stem-cell-research-allowed-to-proceed-again.htm
http://pharma.about.com/b/2011/06/21/weighing-in-on-comparative-effectiveness-drug-trials.htm
http://pharma.about.com/b/2011/04/30/pharmacy-researchers-drill-down-on-patient-adherence.htm
http://pharma.about.com/b/2011/04/28/managed-care-pharmacists-keep-ahead-of-the-curve.htm
http://pharma.about.com/b/2011/05/01/exhibit-hall-hijinks.htm
http://pharma.about.com/b/2011/05/02/long-push-for-new-hepatitis-c-drugs-bears-fruit.htm
http://pharma.about.com/b/2011/05/11/check-up-on-insulin-pill-development.htm
http://pharma.about.com/b/2011/04/17/gsk-puts-alli-and-other-otc-drugs-on-the-block.htm
http://pharma.about.com/b/2011/08/01/johnson-johnson-to-phase-in-lower-dosing-of-tylenol-products.htm
http://pharma.about.com/b/2011/07/07/european-austerity-budgets-target-pharmaceutical-pricing.htm
http://pharma.about.com/b/2011/06/27/researchers-keep-marketers-out-of-clinical-trial-process.htm
http://pharma.about.com/b/2011/08/13/fda-approves-complera-a-daily-pill-for-hiv.htm
http://pharma.about.com/b/2011/08/28/canadian-pharmacy-us-seniors-groups-seek-alternative-to-blanket-ban-on-canadian-online-drug-advertising.htm
http://pharma.about.com/b/2011/08/06/pharma-exec-industry-consolidation-hurts-drug-research.htm
http://pharma.about.com/b/2011/08/07/glaxosmithklines-iraq-deal.htm
http://pharma.about.com/b/2011/08/09/fda-to-address-drug-shortages.htm
http://pharma.about.com/b/2011/08/29/fda-lower-maximum-daily-dose-of-celexa-to-protect-heart.htm
http://pharma.about.com/b/2011/10/26/analysis-of-flu-vaccines-finds-effectiveness-falls-short-of-claims.htm
http://pharma.about.com/b/2011/10/31/obama-takes-executive-action-on-drug-shortages.htm
http://pharma.about.com/b/2011/09/13/pres-obama-to-sign-patent-reform-law-sept-16.htm
http://pharma.about.com/b/2011/10/24/infectious-disease-experts-analyze-physician-views-on-vaccines.htm
http://pharma.about.com/b/2011/10/17/harvard-medical-school-to-apply-systems-approach-to-drug-discovery.htm
http://pharma.about.com/b/2011/10/10/infectious-disease-experts-wanted-new-drugs-now-they-have-them.htm
http://pharma.about.com/b/2011/09/10/a-dozen-pharmas-make-payments-to-physicians-public.htm
http://pharma.about.com/b/2011/09/26/pfizer-expands-its-biomanufacturing-plant-in-ireland.htm
http://pharma.about.com/b/2011/09/10/atrial-fib-drugs-multaq-experience-may-make-it-harder-to-approve-xarelto.htm
http://pharma.about.com/b/2011/09/16/nih-to-facilitate-bench-to-bedside-license-agreements-for-start-up-companies.htm
http://pharma.about.com/b/2011/09/12/another-new-medical-use-for-botulinum-toxin.htm
http://pharma.about.com/b/2011/09/13/supreme-court-sets-date-to-hear-mayo-prometheus-patents-case.htm
http://pharma.about.com/b/2011/09/30/pharmaceutical-exec-blames-fda-inspections-for-drug-shortages.htm
http://pharma.about.com/b/2011/11/30/ama-calls-for-swift-action-on-drug-shortages.htm
http://pharma.about.com/b/2011/12/18/pfizer-plans-to-keep-lipitor-customers-despite-loss-of-patent.htm
http://pharma.about.com/b/2011/12/01/clinicaltrials-gov-still-amazes.htm
http://pharma.about.com/b/2011/11/30/southwest-us-bucks-antibiotic-use-trend.htm
http://pharma.about.com/b/2011/11/30/gop-proposes-no-more-medicare-subsidies-for-millionaires.htm
http://pharma.about.com/b/2011/12/21/2011-top-medical-news-stories-about-drugs.htm
http://pharma.about.com/b/2011/11/28/defense-department-issues-rfps-for-antibiotic-alternatives.htm
http://pharma.about.com/b/2011/11/22/fujifilm-takes-bigger-role-in-biosimilar-development.htm
http://pharma.about.com/b/2011/11/20/fda-revokes-approval-of-avastin-for-breast-cancer.htm
http://pharma.about.com/b/2011/11/07/xarelto-approved-for-stroke-prevention.htm
http://pharma.about.com/b/2011/11/01/study-biomedical-research-papers-have-too-many-innapropriate-authors.htm
http://pharma.about.com/b/2011/10/31/fda-tempers-viibryd-expectations-in-journal-article.htm
http://pharma.about.com/b/2012/01/11/national-academy-of-sciences-call-for-limited-use-of-chimpanzees-in-research.htm
http://pharma.about.com/b/2012/01/09/fda-drug-approvals-up-in-2011.htm
http://pharma.about.com/b/2012/01/13/dissecting-fdas-draft-guidance-on-mobile-medical-apps.htm
http://pharma.about.com/b/2012/01/13/fda-cancer-drug-shortages-price-tags-encourage-counterfeits.htm
http://pharma.about.com/b/2012/01/13/fast-tracked-cancer-drug-implicated-in-brain-inflammation-in-3-patients.htm
http://pharma.about.com/b/2012/01/14/cdc-fatal-prescription-drug-overdose-rate-tripled-since-1990.htm
http://pharma.about.com/b/2012/01/10/fda-to-send-recommendations-on-biosimilar-user-fees-to-congress.htm
http://pharma.about.com/b/2012/01/09/study-newly-identified-compound-could-prevent-sudden-heat-stroke.htm
http://pharma.about.com/b/2012/01/09/novartis-recalls-some-popular-otc-drugs.htm
http://pharma.about.com/b/2012/01/09/no-dissipation-of-controversy-over-hhs-decision-on-plan-b.htm
http://pharma.about.com/b/2011/12/31/procolor-biotech-pursuing-biobetter-for-growth-hormone-deficiencies.htm
http://pharma.about.com/b/2011/12/26/fda-approved-hangover-remedy-ready-for-new-years.htm
http://pharma.about.com/b/2011/12/26/congress-abandons-internet-piracy-bill-favored-by-pharmas-for-now.htm
http://pharma.about.com/b/2011/12/31/wikileaks-cable-haunted-pfizer-in-2011.htm
http://pharma.about.com/b/2012/02/22/fda-panel-votes-20-2-to-approve-qnexa-for-weight-loss.htm
http://pharma.about.com/b/2012/02/22/fda-to-review-aeroshot-an-inhaleable-caffeine.htm
http://pharma.about.com/b/2012/02/29/dallas-doctor-charged-with-largest-medicare-fraud-in-history.htm
http://pharma.about.com/b/2012/03/01/rare-disease-day-highlights-needs.htm
http://pharma.about.com/b/2012/02/16/informed-consent-documents-revised-for-clinical-trials.htm
http://pharma.about.com/b/2012/02/16/fda-counterfeit-avastin-found-in-three-states.htm
http://pharma.about.com/b/2012/02/08/immunization-schedule-updates-for-children-and-adults-published.htm
http://pharma.about.com/b/2012/01/23/pharma-whistleblower-story-gets-picked-up-by-film-producer.htm
http://pharma.about.com/b/2012/01/28/fda-approves-btgs-biologics-license-application-bla-for-voraxaze.htm
http://pharma.about.com/b/2012/01/28/viibryd-and-bystolic-help-forest-labs-exceed-sales-projections.htm
http://pharma.about.com/b/2012/04/23/review-of-adverse-events-finds-little-risk-in-herpes-zoster-shingles-vaccine.htm
http://pharma.about.com/b/2012/04/06/researchers-vast-majority-of-preclinical-cancer-studies-not-reproducible.htm
http://pharma.about.com/b/2012/04/02/phase-3-trial-tevas-laquinimod-reduces-progression-of-relapsing-ms.htm
http://pharma.about.com/b/2012/04/16/fda-counterfeit-cancer-medicines-putting-patients-at-risk.htm
http://pharma.about.com/b/2012/04/09/panel-recommends-full-weight-based-chemotherapy-for-obese-cancer-patients.htm
http://pharma.about.com/b/2012/03/26/eli-lilly-to-introduce-a-dozen-plus-products-in-china.htm
http://pharma.about.com/b/2012/04/24/collaboration-or-just-good-timing.htm
http://pharma.about.com/b/2012/03/20/supreme-court-rules-prometheus-patents-law-of-nature-and-invalid.htm
http://pharma.about.com/b/2012/03/12/microchips-inc-publishes-results-of-osteoporosis-trial.htm
http://pharma.about.com/b/2012/03/11/study-antipsychotic-haloperidol-raises-mortality-risk-in-nursing-homes.htm
http://pharma.about.com/b/2012/03/12/protein-could-be-possible-target-for-obesity-drugs.htm
http://pharma.about.com/b/2012/03/18/fda-seeks-input-on-modernizing-clinical-trials-regs.htm
http://pharma.about.com/b/2012/03/18/takedas-new-diabetes-drug-reduces-hypoglycemia-risk-in-phase-2-trial.htm
http://pharma.about.com/b/2012/05/31/senate-rejects-effort-to-relax-drug-importation-rules.htm
http://pharma.about.com/b/2012/06/17/computer-model-may-help-weed-out-unsafe-drugs.htm
http://pharma.about.com/b/2012/05/28/fda-approves-11-generics-for-plavix.htm
http://pharma.about.com/b/2012/06/10/anticoagulants-lead-in-adverse-event-reports.htm
http://pharma.about.com/b/2012/05/12/researchers-fool-opioid-receptors-into-strengthening-immune-system.htm
http://pharma.about.com/b/2012/04/30/drugs-approved-for-pediatric-use.htm
http://pharma.about.com/b/2012/05/14/lenalidomide-improved-outcomes-for-multiple-myeloma-after-stem-cell-transplants.htm
http://pharma.about.com/b/2012/05/03/whos-tops-in-pharma-ceo-salaries.htm
http://pharma.about.com/b/2012/05/02/three-new-ms-drugs-could-reach-the-market-in-2012-13.htm
http://pharma.about.com/b/2012/04/30/many-reasons-for-gardasils-slow-sales.htm
http://pharma.about.com/b/2012/05/01/antibiotic-approved-to-treat-and-prevent-plague.htm
http://pharma.about.com/b/2012/04/29/fda-to-co-sponsor-industry-cgmp-conference.htm
http://pharma.about.com/b/2012/06/30/making-a-better-drug-compound.htm
http://pharma.about.com/b/2012/07/17/will-new-branded-prescription-drug-fee-drive-up-costs.htm
http://pharma.about.com/b/2012/07/16/half-of-london-olympics-athletes-will-undergo-drug-testing-at-gsk-anti-doping-lab.htm
http://pharma.about.com/b/2012/06/30/study-use-bodys-immune-response-to-limit-tb-bacteria-growth.htm
http://pharma.about.com/b/2012/07/18/european-medicines-agency-warms-pharma-reps-theyll-be-watched-during-olympics.htm
http://pharma.about.com/b/2012/07/25/eu-regulators-cracking-down-on-pay-for-delay.htm
http://pharma.about.com/b/2012/06/28/phrma-weighs-in-on-scotus-ruling.htm
http://pharma.about.com/b/2012/07/30/companies-release-new-clinical-trials-results.htm
http://pharma.about.com/b/2012/06/23/nhs-accuses-pharmas-of-creating-drug-shortages.htm
http://pharma.about.com/b/2012/06/27/eli-lilly-launches-diagnostic-tracer-for-alzheimers-disease.htm
http://pharma.about.com/b/2012/07/18/british-athletes-promote-drug-free-winning-in-gsks-olympic-ads.htm
http://pharma.about.com/b/2012/08/11/ftc-approves-drug-shortages-plan.htm
http://pharma.about.com/b/2012/09/15/french-doctors-claim-half-of-prescription-drugs-are-useless.htm
http://pharma.about.com/b/2012/09/06/anti-obesity-pill-qsymia-to-reach-market-in-4th-quarter.htm
http://pharma.about.com/b/2012/08/31/under-generic-drug-act-cros-must-log-company-details-with-the-fda.htm
http://pharma.about.com/b/2012/08/10/wto-seeks-international-aid-for-syrias-severe-drug-shortages.htm
http://pharma.about.com/b/2012/07/31/drug-abuse-through-the-ages.htm
http://pharma.about.com/b/2012/08/20/emerging-market-slowdown.htm
http://pharma.about.com/b/2012/08/24/legislator-seeks-coordination-on-autoimmune-disease-research-therapy.htm
http://pharma.about.com/b/2012/08/26/new-uses-for-antidepressants.htm
http://pharma.about.com/b/2012/08/30/solanezumab-trials-in-alzheimers-disease-continue.htm
http://pharma.about.com/b/2012/08/26/pharmas-making-up-some-losses-in-emerging-markets.htm
http://pharma.about.com/b/2012/09/30/depomed-files-suit-against-fda-over-orphan-drug-status.htm
http://pharma.about.com/b/2012/09/30/know-your-health-care-bureaucracy.htm
http://pharma.about.com/b/2012/10/01/mit-researchers-propose-megafund-for-cancer-drug-discovery.htm
http://pharma.about.com/b/2012/09/29/deluge-of-inquiries-follow-article-on-addiction-medication.htm
http://pharma.about.com/b/2012/10/05/fda-withdraws-approval-of-tevas-budeprion-xl-300-mg-citing-lack-of-bioequivalency.htm
http://pharma.about.com/b/2012/10/05/no-slow-down-in-pharma-settlements.htm
http://pharma.about.com/b/2012/10/14/are-pharmas-planning-to-offshore-more-jobs.htm
http://pharma.about.com/b/2012/10/28/study-glaucoma-drug-helps-balding-men-regrow-hair.htm
http://pharma.about.com/b/2012/09/28/more-addiction-drugs-are-entering-the-pipeline.htm
http://pharma.about.com/b/2012/09/30/new-technologies-spur-global-api-market-growth.htm
http://pharma.about.com/b/2012/09/26/pharma-topics-among-free-online-education-offerings.htm
http://pharma.about.com/b/2012/09/26/merck-no-longer-has-budget-to-support-alec.htm
http://pharma.about.com/b/2012/09/30/judging-a-company-by-the-way-they-treat-their-postdocs.htm
http://pharma.about.com/b/2012/11/30/male-birth-control-pill-due-soon.htm
http://pharma.about.com/b/2012/11/24/under-fda-review-insomnia-drug-that-minimizes-grogginess.htm
http://pharma.about.com/b/2012/10/31/ad-companies-say-pharma-spending-is-down.htm
http://pharma.about.com/b/2012/10/31/fda-releases-draft-guidance-for-dmf-submissions.htm
http://pharma.about.com/b/2012/10/31/mini-poll-pfizers-social-media-presence-is-strongest.htm
http://pharma.about.com/b/2012/11/04/drug-crisis-in-greece-deepens.htm
http://pharma.about.com/b/2012/11/24/international-directory-of-pharmas-published.htm
http://pharma.about.com/b/2012/11/30/russias-pharma-industry-suffering-from-administrative-pains.htm
http://pharma.about.com/b/2012/11/26/unaids-will-host-google-hangout-on-november-27.htm
http://pharma.about.com/b/2012/10/30/after-2-years-of-patent-losses-some-pharmas-show-resilience.htm
http://pharma.about.com/b/2012/11/30/new-version-of-dsm-to-be-voted-on-this-weekend.htm
http://pharma.about.com/b/2012/10/31/aers-data-shows-viibryd-post-market-adverse-events-consistent-with-clinical-trials-outcomes.htm
http://pharma.about.com/b/2012/12/30/eliquis-approved-for-reduction-of-stroke-risk-in-patients-with-atrial-fibrillation.htm
http://pharma.about.com/b/2012/12/31/un-body-to-take-up-draft-treaty-on-mercury-including-a-ban-on-thimerosal-in-vaccines.htm
http://pharma.about.com/b/2012/12/30/pharmas-rush-to-pay-investor-dividends-before-tax-increase.htm
http://pharma.about.com/b/2012/12/29/ga-researchers-canine-virus-may-be-useful-for-human-vaccine-delivery.htm
http://pharma.about.com/b/2012/12/23/new-hep-c-drug-increases-risk-of-serious-skin-reactions.htm
http://pharma.about.com/b/2012/12/18/rapid-economic-growth-drives-africa-drug-market.htm
http://pharma.about.com/b/2012/12/18/lorus-therapeutics-and-brock-university-proceed-with-plant-based-cancer-therapy.htm
http://pharma.about.com/od/Government_IP/a/U-S-Policy-On-Drug-Importation.htm
http://pharma.about.com/od/BigPharma/u/Issues.htm
http://pharma.about.com/
http://pharma.about.com/od/Over-the-Counter-Medicine/a/The-Over-the-counter-Drug-Industry.htm
http://pharma.about.com/od/B/g/Biosafety-Levels.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011_3.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011_4.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011_2.htm
http://pharma.about.com/od/P/g/Protein-Misfolding-Diseases.htm
http://pharma.about.com/od/Philanthropy/a/Pharmas-And-Corporate-Philanthropy.htm
http://pharma.about.com/od/O/g/Orphan-Drugs.htm
http://pharma.about.com/od/Over-the-Counter-Medicine/a/Over-The-Counter-Drugs-Theres-A-Recipe-For-That.htm
http://pharma.about.com/od/Over-the-Counter-Medicine/a/Behind-The-Counter-Drugs.htm
http://pharma.about.com/od/BigPharma/p/Pfizer.htm
http://pharma.about.com/od/BigPharma/a/Side-Effects-Associated-With-Gardasil.htm
http://pharma.about.com/od/A/g/Adverse-Event-Reporting-Aer.htm
http://pharma.about.com/od/D/g/Drug-Master-File-Dmf.htm
http://pharma.about.com/od/B/g/Bioavailability.htm
http://pharma.about.com/od/Research-and-Development/a/A-Paradigm-Shift-In-Alzheimers-Diagnosis.htm
http://pharma.about.com/od/A/g/Api-Active-Pharmaceutical-Ingredient.htm
http://pharma.about.com/od/N/g/National-Drug-Code-Ndc.htm
http://pharma.about.com/od/B/g/Biobetter.htm
http://pharma.about.com/od/BigPharma/tp/Big-Pharmas-Merger-Mania.htm
http://pharma.about.com/od/BigPharma/tp/Big-Ten-Branded-Drug-Blockbusters-Of-2010.htm
http://pharma.about.com/od/N/g/New-Drug-Application-Nda.htm
http://pharma.about.com/od/Philanthropy/a/Pharma-Partners-Pledge-1-4-Billion-Annually-To-Eradicate-Tropic.htm
http://pharma.about.com/od/A/g/Authorized-Generic-Definition.htm
http://pharma.about.com/od/M/g/Medically-Necessary.htm
http://pharma.about.com/od/Government_IP/u/Regulations.htm
http://pharma.about.com/od/Government_IP/a/Health-Care-Reform-Implementation-Schedule-For-Pharmas.htm
http://pharma.about.com/od/BigPharma/tp/Top-U-S-Pharmas.htm
http://pharma.about.com/od/A/g/Abbreviated-New-Drug-Application.htm
http://pharma.about.com/od/C/g/Comparative-Effectiveness-Research-Cer.htm
http://pharma.about.com/od/B/g/Background-Contamination.htm
http://pharma.about.com/od/B/g/Black-Box-Warning.htm
http://pharma.about.com/b/a/200603.htm